Endocrine Research Updates

For Medical Professionals

Screening and treatment for osteoporosis is essential to avoid bone fractures.
With hip fractures rates on the rise, a concerted effort is needed to revisit regular bone screenings, and bisphosphonate treatment including education about the reality of side effects.
Patients with diabetes benefit from newly introduced apps and devices to support
New medical device regulations, devices, and software to inform your practice and trial with your patients.
Obesity in metabolic disease is due to poor mitochondrial function.
Implications for intransigent obesity may be related first to your patients’ metabolic inflexibility and only secondarily to their diet, and may offer an early warning sign of diabetes. .
Proposed new guidelines challenge current recommendations to improve management
Peer-reviewed recommendations to change the diagnosis criteria and treatment considerations for thyroid storm reflect observed patient experiences that go beyond current common sense practices.
Eating more mindfully and increasing physical activity will reduce CVD risk.
Addressing behaviors such as diet, physical activity, weight, and smoking appear to mediate development of cardiovascular disease in women who had gestational diabetes.
Harvard researchers present evidence that low TSH adversely affects fertility.
Slightly low thyroid stimulating hormone levels may offer a reason why some women struggle to get pregnant suggest Harvard researchers.
PCOS puts women at twice the risk for non-alcoholic fatty liver disease.
PCOS puts women at increased risk for steatosis and fibrosis with insulin resistance and hyperandrogenism as key factors in liver damage of these patients.
Giving breastfed babie good gut bacteria may improve their longterm health.
Boosting gut microflora may yield improvements linked to reduced dysbiosis, and potential for long-term benefit against chronic diseases.
Personalized glycemic (hemoglobin A1C) goals promise better outcomes.
Taking a patient-centered approach to glycemic goals rather than intensive HbA1C targets promises substantially reduced costs and improve quality of life over the lifetime.
A case for using postprandial insulin over glucose level to predict diabetes.
While promising, there is no way to know whether introducing lifestyle changes to patients who are diagnosed earlier will positively effect their outcomes.
Variability in pediatric thyroid reference ranges lessens an accurate diagnosis.
Recent research uncovers a wide variation in reference ranges for pediatric thyroid function and points to possible factors affecting thyroid hormone levels in children.
Symptoms of type 2 diabetes may prediction disease progression
Researchers followed patients who were newly diagnosed with type 2 diabetes for 18 months to classify their disease progression based on 20 baseline symptoms.
Direct intervention with an assigned appointment specialist dramatically improved retention rates and better disease outcomes among pediatric patients with type 1 Diabetes as they were transitioned to adult care.
New criteria downgrade staging for many patients with papillary thyroid cancer.
Changes to the eighth edition of the American Joint Commission on Cancer/Union for International Cancer Control 's criteria for tumor staging offer better prognosis for many patients diagnosed with papillary thyroid cancer.
Bioidentical hormones are preceived as natural but pose greater harm than HRT.
Two internationally recognized women's health experts raise concerns from use of hormone therapy from a compounding pharmacy to manage menopausal symptoms.
Ultra-rapid injectable mealtime insulin receives FDA approval
A new ultra-rapid injectable synthetic insulin has been added to Novo Nordisk's antidiabetes product line-up.
Analyses of insulinomas provide pathway to pharmacologically target genes and gene families that may restore function of beta cells in individuals with type 1 and type 2 diabetes.
The lower the LDL the better with a combination of a statin and PSK9-inhibitor.
A secondary analysis of the Fourier study findings indicates that patients with the lowest LDL had best cardiovascular outcomes.
Asymptomatic thyroid disease may arise following cancer treatment with ICI.
There is a growing need for endocrinologists to be better prepared regarding management of thyroid diseases that may develop in oncology patients as a result of treatment with immune checkpoint inhibitors.
close X